ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 317 filers reported holding ROYALTY PHARMA PLC in Q3 2022. The put-call ratio across all filers is 0.29 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $11,712,158 | +24.8% | 431,546 | +41.3% | 0.05% | +31.6% |
| Q2 2023 | $9,386,951 | -52.3% | 305,366 | -44.1% | 0.04% | -56.3% |
| Q1 2023 | $19,698,826 | +87.2% | 546,734 | +105.3% | 0.09% | +70.6% |
| Q4 2022 | $10,524,136 | +55.8% | 266,299 | +58.3% | 0.05% | +45.7% |
| Q3 2022 | $6,757,000 | -36.5% | 168,173 | -33.6% | 0.04% | -32.7% |
| Q2 2022 | $10,647,000 | -7.2% | 253,266 | -14.0% | 0.05% | +15.6% |
| Q1 2022 | $11,470,000 | +57.9% | 294,399 | +61.5% | 0.04% | +66.7% |
| Q4 2021 | $7,266,000 | -41.0% | 182,331 | -46.5% | 0.03% | -51.8% |
| Q3 2021 | $12,323,000 | -69.0% | 340,979 | -64.8% | 0.06% | -68.0% |
| Q2 2021 | $39,761,000 | +2.4% | 970,006 | +9.0% | 0.18% | -0.6% |
| Q1 2021 | $38,811,000 | +196.9% | 889,751 | +240.7% | 0.18% | +214.3% |
| Q4 2020 | $13,070,000 | – | 261,145 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Siguler Guff Advisers, LLC | 3,391,754 | $92,052,204 | 47.04% |
| Indie Asset Partners, LLC | 433,000 | $11,751,620 | 11.84% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 4,095,745 | $111,158,519 | 6.01% |
| Advanced Portfolio Management, LLC | 230,000 | $6,242,200 | 5.25% |
| Compound Global Advisors, LLC | 626,412 | $17,000,822 | 3.73% |
| Geo Capital Gestora de Recursos Ltd | 135,079 | $3,666 | 3.39% |
| TORRAY INVESTMENT PARTNERS LLC | 412,633 | $11,198,860 | 1.98% |
| Overbrook Management Corp | 298,712 | $8,107,044 | 1.89% |
| Silicon Valley Community Foundation | 358,270 | $9,723,448 | 1.18% |
| Greytown Advisors Inc. | 74,601 | $2,024,671 | 1.12% |